share_log

Is Allmed Medical Products Co.,Ltd's (SZSE:002950) Stock Price Struggling As A Result Of Its Mixed Financials?

Is Allmed Medical Products Co.,Ltd's (SZSE:002950) Stock Price Struggling As A Result Of Its Mixed Financials?

是Allmed医疗产品有限公司吗,Ltd(深圳证券交易所:002950)的股价因其财务状况好坏参半而陷入困境?
Simply Wall St ·  01/18 22:48

Allmed Medical ProductsLtd (SZSE:002950) has had a rough month with its share price down 8.8%. It is possible that the markets have ignored the company's differing financials and decided to lean-in to the negative sentiment. Long-term fundamentals are usually what drive market outcomes, so it's worth paying close attention. Particularly, we will be paying attention to Allmed Medical ProductsLtd's ROE today.

Allmed Medical ProductsLtd(深圳证券交易所:002950)经历了艰难的一个月,其股价下跌了8.8%。市场可能忽视了该公司不同的财务状况,决定倾向于负面情绪。长期基本面通常是推动市场结果的因素,因此值得密切关注。特别是,我们今天将关注Allmed Medical ProductsLtd的投资回报率。

Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. Put another way, it reveals the company's success at turning shareholder investments into profits.

股本回报率或投资回报率是用于评估公司管理层利用公司资本效率的关键指标。换句话说,它揭示了公司成功地将股东投资转化为利润。

See our latest analysis for Allmed Medical ProductsLtd

查看我们对Allmed Medical ProductsLTD的最新分析

How To Calculate Return On Equity?

如何计算股本回报率?

Return on equity can be calculated by using the formula:

股本回报率可以使用以下公式计算:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

股本回报率 = 净利润(来自持续经营业务)÷ 股东权益

So, based on the above formula, the ROE for Allmed Medical ProductsLtd is:

因此,根据上述公式,Allmed Medical ProductsLtd的投资回报率为:

11% = CN¥353m ÷ CN¥3.2b (Based on the trailing twelve months to September 2023).

11% = 3.53亿元人民币 ÷ 32亿元人民币(基于截至2023年9月的过去十二个月)。

The 'return' refers to a company's earnings over the last year. Another way to think of that is that for every CN¥1 worth of equity, the company was able to earn CN¥0.11 in profit.

“回报” 是指公司去年的收益。另一种看法是,每持有价值1元人民币的股权,公司就能获得0.11元人民币的利润。

What Has ROE Got To Do With Earnings Growth?

投资回报率与收益增长有什么关系?

So far, we've learned that ROE is a measure of a company's profitability. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics.

到目前为止,我们已经了解到,投资回报率是衡量公司盈利能力的指标。现在,我们需要评估公司再投资或 “保留” 了多少利润以用于未来的增长,从而使我们对公司的增长潜力有所了解。假设其他一切保持不变,那么与不一定具有这些特征的公司相比,投资回报率和利润保留率越高,公司的增长率就越高。

A Side By Side comparison of Allmed Medical ProductsLtd's Earnings Growth And 11% ROE

Allmed Medical ProductsLtd的收益增长和11%的投资回报率的并排比较

On the face of it, Allmed Medical ProductsLtd's ROE is not much to talk about. However, its ROE is similar to the industry average of 9.3%, so we won't completely dismiss the company. Still, Allmed Medical ProductsLtd has seen a flat net income growth over the past five years. Remember, the company's ROE is not particularly great to begin with. So that could also be one of the reasons behind the company's flat growth in earnings.

从表面上看,Allmed Medical ProductsLtd的投资回报率没什么好谈的。但是,其投资回报率与行业平均水平的9.3%相似,因此我们不会完全解散该公司。尽管如此,在过去五年中,Allmed Medical ProductsLTD的净收入增长仍然持平。请记住,公司的投资回报率一开始并不是特别好。因此,这也可能是该公司收益持平增长的原因之一。

As a next step, we compared Allmed Medical ProductsLtd's net income growth with the industry and discovered that the industry saw an average growth of 16% in the same period.

下一步,我们将Allmed Medical ProductsLtd的净收入增长与该行业进行了比较,发现该行业同期的平均增长率为16%。

past-earnings-growth
SZSE:002950 Past Earnings Growth January 19th 2024
SZSE: 002950 过去的收益增长 2024 年 1 月 19 日

Earnings growth is an important metric to consider when valuing a stock. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. This then helps them determine if the stock is placed for a bright or bleak future. Is Allmed Medical ProductsLtd fairly valued compared to other companies? These 3 valuation measures might help you decide.

收益增长是对股票进行估值时要考虑的重要指标。无论情况如何,投资者都应设法确定预期的收益增长或下降是否已计入其中。然后,这可以帮助他们确定股票是为光明还是暗淡的未来而布局。与其他公司相比,Allmed Medical ProductsLtd的估值是否合理?这3种估值指标可能会帮助您做出决定。

Is Allmed Medical ProductsLtd Efficiently Re-investing Its Profits?

Allmed Medical ProductsLtd是否有效地将其利润再投资?

Despite having a normal three-year median payout ratio of 28% (implying that the company keeps 72% of its income) over the last three years, Allmed Medical ProductsLtd has seen a negligible amount of growth in earnings as we saw above. So there might be other factors at play here which could potentially be hampering growth. For example, the business has faced some headwinds.

尽管在过去三年中,Allmed Medical ProductsLTD的三年派息率中位数为28%(这意味着该公司保留了收入的72%),但正如我们上面所看到的,其收益增长微不足道。因此,这里可能还有其他因素在起作用,这些因素可能会阻碍增长。例如,该业务面临一些阻力。

Additionally, Allmed Medical ProductsLtd has paid dividends over a period of five years, which means that the company's management is determined to pay dividends even if it means little to no earnings growth.

此外,Allmed Medical ProductsLTD已在五年内派发了股息,这意味着即使收益增长微乎其微,公司的管理层也决心支付股息。

Summary

摘要

Overall, we have mixed feelings about Allmed Medical ProductsLtd. While the company does have a high rate of profit retention, its low rate of return is probably hampering its earnings growth. So far, we've only made a quick discussion around the company's earnings growth. To gain further insights into Allmed Medical ProductsLtd's past profit growth, check out this visualization of past earnings, revenue and cash flows.

总的来说,我们对奥美医疗产品有限公司的看法喜忧参半。尽管该公司的利润保留率确实很高,但其低回报率可能会阻碍其收益增长。到目前为止,我们仅就公司的收益增长进行了简短的讨论。要进一步了解Allmed Medical ProductsLTD过去的利润增长,请查看这份过去收益、收入和现金流的可视化图表。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发